MMAF is a synthetic peptide-like compound used as a pharmaceutical intermediate in the manufacturing of complex organic molecules. Its structure features multiple amide bonds, an aromatic ring, and ether groups, contributing to its role in specialized chemical synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 745017-94-1
Auristatin F
pharmaceutical raw material
Monomethyl auristatin E
pharmaceutical intermediate
Vedotin
pharmaceutical intermediate
Monomethylauristatin D
pharmaceutical raw material
4-[1-methoxy-2-(methylamino)ethyl]benzene-1,2-diol hydrochloride
pharmaceutical intermediate
3,5-Difluoropyridine-2-carboxylic acid
pharmaceutical intermediate
(S)-3-AMINO-2-METHYLBUTAN-2-OL
pharmaceutical intermediate
Methyl 4-piperidinecarboxylate
pharmaceutical intermediate
(2S)-2-[[(2R,3R)-3-methoxy-3-[(2S)-1-[(3R,4S,5S)-3-methoxy-5-methyl-4-[methyl-[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(methylamino)butanoyl]amino]butanoyl]amino]heptanoyl]pyrrolidin-2-yl]-2-methylpropanoyl]amino]-3-phenylpropanoic acid
MFRNYXJJRJQHNW-DEMKXPNLSA-N
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC